Published in

Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Cadernos de Saúde Pública, 4(23), p. 815-822, 2007

DOI: 10.1590/s0102-311x2007000400009

Links

Tools

Export citation

Search in Google Scholar

No difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

A comparative study was performed on the initial and final bacillary indexes of 213 multibacillary leprosy patients who received 12 doses (Group 1: 128 patients) or 24 doses (Group 2: 85 patients) of multidrug therapy (MDT/WHO) to measure the effectiveness of the two regimens. All patients were evaluated at treatment baseline, 12 months, and 24 months. The reduction in bacillary levels and mean bacillary indexes at 24 months was similar in the two groups. No statistical difference in reaction rates was observed between the two treatment regimens.